Virginia Department of Health Professions

The quality (e.g., National Formulary, American Chemical Society) of the inactive ingredients should be cited. For novel excipients, additional manufacturing information may be necessary. Where applicable, a brief summary of the quantitative composition of the investigational new drug product, including any reasonable variations that may be ... ................
................

In order to avoid copyright disputes, this page is only a partial summary.